Related Experiment Video
Updated: Nov 26, 2025
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.1K
Global Pediatric Regulations: An Overview.
Priya M Gadge1, Prathmesh P Kenjale2, Varsha B Pokharkar3
1Department of Drug Regulatory Affairs, BVDU Poona College of Pharmacy, Pune, Maharashtra, India.
Therapeutic Innovation & Regulatory Science
|December 10, 2020
Summary
Pediatric drug development requires specific regulations due to children's unique physiology. Current pediatric drug laws need enhancement to ensure patient safety and efficacy, addressing the "therapeutic orphans" issue.
Area of Science:
- Pharmacology
- Pediatrics
- Regulatory Science
Background:
- Adult and pediatric physiological conditions differ significantly, necessitating distinct drug dosage regimens.
- Children exhibit unique pharmacokinetic and pharmacodynamic characteristics, requiring reconfirmation of drug effects.
- Many drugs used in pediatric care are considered "therapeutic orphans" due to development challenges and insufficient data.
Purpose of the Study:
- To review current pediatric regulatory requirements for drug development.
- To identify necessary regulatory efforts for improving pediatric patient safety and efficacy.
- To highlight the need for focused attention on pediatric drug development laws.
Main Methods:
- Literature review of current pediatric regulatory frameworks.
- Analysis of existing regulatory efforts and their impact.
- Identification of gaps in pediatric drug development regulations.
Main Results:
- Current pediatric regulatory requirements are insufficient for optimal drug development.
- Significant regulatory efforts are needed to ensure pediatric drug safety and efficacy.
- Pediatric drug development faces challenges due to limited clinical trials and data.
Conclusions:
- Existing pediatric drug regulations require substantial enhancement.
- Focused regulatory strategies are crucial to address the needs of pediatric patients.
- International regulatory bodies play a key role in administering pediatric drug regulations.
Keywords:
Pediatric Investigation PlanPediatric Review Committeepediatric clinical studypediatric regulationMore Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
51.3K
15:18Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
18.5K
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
109
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
111
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
111
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
137
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
137
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
91
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
91
01:25Drug Regulation
2.5K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.5K
01:29Drug Dosing: Infants and Children
111
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
111